Precision Motion for Research

The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights. […]

Read More… from Precision Motion for Research

Advancing Alzheimer’s Clinical Trial Endpoints: Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk

Clario awarded SAS Global Service Provider Partner of the Year

Ophthalmology

Advance ophthalmic therapeutic from study start-up to regulatory submission with proven site support, project management, and medical expertise. […]

Read More… from Ophthalmology

Clario and Cleveland Clinic’s Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials

The New Liver Lexicon

Knowledge is Power

Revolutionizing Oncology Clinical Trials:  The Transformative Power and Promise of AI-Enhanced Medical Imaging

Designing a successful imaging-based pediatric oncology trial

Don’t compromise your oncology trial before it begins

Unlock oncology trial success with Clario

Advancing Electronic Clinical Outcome Assessments

Site-Based Spirometry (FEV₁, FVC, PEF, and more.)

Centralized, on-site pulmonary function testing for clinical trials. […]

Read More… from Site-Based Spirometry (FEV₁, FVC, PEF, and more.)

How the recent FDA & EMA regulations are helping advance and enhance Electronic Clinical Outcome Assessments (eCOA/ePRO)

Trials large and small benefit from Clario scientists

Learn amazing things from Clario science teams